|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
425.800 +4.800 (+1.140%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 2,057,920 | 6.460% | 1,933,045 | 1,540,493 | 803,933 | 32,322 |
| Cost of Sales | (579,139) | -12.170% | (659,388) | (781,308) | (276,828) | (20,525) |
| Gross Profit | 1,478,781 | 16.105% | 1,273,657 | 759,185 | 527,105 | 11,797 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (355,780) | 149.591% | (142,545) | (467,692) | (567,364) | (889,795) | |
| Taxation | (26,191) | -78.916% | (124,221) | (106,442) | (48,735) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (381,971) | 43.186% | (266,766) | (574,134) | (616,099) | (889,795) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,158 | -- | (30,381) | 39,123 | 147,397 | 111,785 |
| Depreciation & Amortisation | -- | -- | 91,386 | 75,076 | 67,364 | 22,914 |
| Directors' Emoluments | -- | -- | 32,162 | 22,574 | 7,942 | 13,106 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -166.000 | 38.333% | -120.000 | -284.000 | -574.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.782) | -- | (1.939) | 0.324 | (2.836) | -- |
| NBV per share ($) | 20.872 | -- | 14.558 | 10.627 | -- | -- |
| Remarks: | Real time quote last updated: 25/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -381,971 |
| %Change | 43.186% |
| EPS / (LPS) | RMB -1.660 |
| NBV Per Share (¥) | RMB 20.872 |